LIDOCAINE HCl
LIDOCAINE HCl INJECTION, USP 1% 20mg/2mL (10mg/mL) 2mL AMP
Approved
Approval ID
e39435a3-1f69-78c5-e053-2995a90a7fc3
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 27, 2024
Manufacturers
FDA
HF Acquisition Co LLC, DBA HealthFirst
DUNS: 045657305
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
LIDOCAINE HCl
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code51662-1593
Application NumberANDA080408
Product Classification
M
Marketing Category
C73584
G
Generic Name
LIDOCAINE HCl
Product Specifications
Route of AdministrationINFILTRATION, PERINEURAL, INTRACAUDAL, EPIDURAL
Effective DateJanuary 27, 2024
FDA Product Classification
INGREDIENTS (5)
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
LIDOCAINE HYDROCHLORIDEActive
Quantity: 10 mg in 1 mL
Code: V13007Z41A
Classification: ACTIR
SODIUM CHLORIDEInactive
Quantity: 7 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT